Symbiotec Pharmalab Sees Mirae Asset Mutual Fund Acquire 5.44% Stake

2 September 2026

Symbiotec Pharmalab Ltd.

Mirae Asset Mutual Fund; promoter: No; before: 498,019; after: 3,995,439; mode: Open Market.

Recent Events

Symbiotec Arm Signs Exclusive US Deal For Two DCV Injectables

Symbiotec Pharmalab Recreates Promoter Pledges Covering 12.82% Of Share Capital

Symbiotec Pharmalab Discloses 5.44% Promoter Share Pledge To Beacon Trusteeship

Get features of